Insulet Corp. Company Profile (NASDAQ:PODD)

About Insulet Corp.

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The OmniPod System consists of the OmniPod, a small, self-adhesive disposable tubeless OmniPod device, which is worn on the body for approximately three days at a time and its wireless handheld Personal Diabetes Manager (PDM). The Company purchases OmniPods pursuant to its agreement with Flextronics. It also partners with pharmaceutical and biotechnology companies to tailor the OmniPod technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas. It sells the OmniPod System and other diabetes management supplies in the United States through direct sales to customers or through its distribution partners. The Company purchases OmniPods pursuant to its agreement with Flextronics. The OmniPod System is available in Europe, Canada and Israel.

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Instruments & Supplies
Sub-Industry: Health Care Equipment
Exchange: NASDAQ
Symbol: PODD
CUSIP: 45784P10

Key Metrics:

Previous Close: $43.77
50 Day Moving Average: $43.08
200 Day Moving Average: $34.76
52-Week Range: $23.94 - $45.60
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -312.64
P/E Growth: -3.93
Market Cap: $2.51B
Outstanding Shares: 57,267,000
Beta: 1.28

Profitability:

Net Margins: -17.68%
Return on Equity: -137.88%
Return on Assets: -18.16%

Debt:

Debt-to-Equity Ratio: 6.40%
Current Ratio: 3.29%
Quick Ratio: 2.84%

Additional Links:

Companies Related to Insulet Corp.:

Consensus Ratings for Insulet Corp. (NASDAQ:PODD) (?)

Ratings Breakdown:	8 Hold Ratings, 8 Buy Ratings
Consensus Rating:	Buy (Score: 2.50)
Consensus Price Target:	$40.92 (6.50% downside)

Analysts' Ratings History for Insulet Corp. (NASDAQ:PODD)

Show:

Date	Firm	Action	Rating	Price Target
9/26/2016	B. Riley	Initiated Coverage	Neutral	$46.00
8/17/2016	JPMorgan Chase & Co.	Reiterated Rating	Hold	$38.00
8/16/2016	Piper Jaffray Cos.	Reiterated Rating	Overweight	$52.00
8/5/2016	Canaccord Genuity	Reiterated Rating	Hold	$36.00
8/4/2016	Leerink Swann	Reiterated Rating	Outperform	$40.00 -> $50.00
8/4/2016	Jefferies Group	Boost Price Target	Buy	$41.00 -> $45.00
8/4/2016	Wedbush	Boost Price Target	Outperform	$44.00 -> $48.00
7/12/2016	BTIG Research	Initiated Coverage	Neutral
5/16/2016	Sterne Agee CRT	Reiterated Rating	Neutral
4/29/2016	William Blair	Upgrade	Market Perform -> Outperform
2/26/2016	Feltl & Co.	Upgrade	Hold -> Buy	$35.00
2/26/2016	Benchmark Co.	Upgrade	Hold -> Buy	$30.00 -> $40.00
2/22/2016	Robert W. Baird	Lower Price Target	Neutral	$35.00 -> $30.00
1/7/2016	Cowen and Company	Boost Price Target		$40.00
12/3/2015	Northland Securities	Reiterated Rating	Market Perform
11/2/2015	Morgan Stanley	Initiated Coverage	Equal -> Equal Weight	$32.00
5/1/2015	Oppenheimer Holdings Inc.	Lower Price Target	Market Perform	$33.00 -> $31.00
1/15/2015	Raymond James Financial Inc.	Downgrade	Outperform -> Market Perform
11/6/2014	JMP Securities	Reiterated Rating	Market Outperform	$9.00 -> $10.00
11/4/2014	Northcoast Research	Initiated Coverage	Neutral

(Data available from 9/28/2014 forward)

Earnings History for Insulet Corp. (NASDAQ:PODD)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/3/2016
8/3/2016	Q216	($0.17)	($0.08)	$81.10 million	$87.30 million	View	N/A
4/28/2016	Q116	($0.19)	($0.19)	$79.06 million	$81.21 million	View	Listen
2/25/2016	Q415	($0.26)	($0.48)	$91.89 million	$100.10 million	View	Listen
11/5/2015	Q315	($0.26)	($0.33)	$83.56 million	$87.30 million	View	Listen
8/12/2015	Q215	($0.13)	($0.27)	$70.32 million	$75.60 million	View	Listen
4/30/2015	Q115	($0.10)	($0.21)	$68.20 million	$61.20 million	View	N/A
2/26/2015	Q414	($0.04)	($0.10)	$73.52 million	$72.60 million	View	N/A
8/7/2014	Q214	($0.08)	($0.06)	$72.94 million	$72.00 million	View	N/A
5/7/2014	Q114	($0.06)	($0.11)	$68.47 million	$69.20 million	View	N/A
2/27/2014	Q413	($0.09)	($0.04)	$67.94 million	$68.53 million	View	N/A
11/7/2013	Q313	($0.16)	($0.39)	$62.01 million	$61.10 million	View	N/A
8/7/2013	Q2 2013	($0.19)	($0.20)	$60.47 million	$60.09 million	View	N/A
5/6/2013	Q1 2013	($0.21)	($0.20)	$57.26 million	$57.40 million	View	N/A
2/27/2013	Q4 2012	($0.21)	($0.21)	$59.12 million	$57.80 million	View	N/A
11/8/2012	Q312	($0.22)	($0.26)	$54.93 million	$54.80 million	View	N/A
8/8/2012		($0.25)	($0.30)			View	N/A
5/9/2012		($0.28)	($0.31)			View	N/A
2/9/2012		($0.26)	($0.30)			View	N/A
11/3/2011		($0.25)	($0.29)			View	N/A
8/2/2011		($0.21)	($0.42)			View	N/A
5/9/2011		($0.22)	($0.22)			View	N/A
2/15/2011		($0.26)	($0.50)			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Insulet Corp. (NASDAQ:PODD)

Current Year EPS Consensus Estimate: $-0.41 EPS
Next Year EPS Consensus Estimate: $-0.14 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.29)	($0.29)	($0.29)
Q2 2016	3	($0.21)	($0.14)	($0.18)
Q3 2016	6	($0.09)	($0.04)	($0.08)
Q4 2016	7	($0.10)	($0.05)	($0.07)
Q1 2017	3	($0.10)	($0.02)	($0.07)
Q2 2017	3	($0.05)	$0.00	($0.02)
Q3 2017	3	($0.01)	$0.02	$0.01
Q4 2017	3	$0.01	$0.03	$0.02
Q1 2018	1	$0.06	$0.06	$0.06
Q2 2018	1	$0.10	$0.10	$0.10

(Data provided by Zacks Investment Research)

Dividend History for Insulet Corp. (NASDAQ:PODD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Insulet Corp. (NASDAQ:PODD)

Insider Ownership Percentage: 1.90%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
5/25/2016	Regina O Sommer	Director	Sell	8,019	$30.42	$243,937.98
5/18/2016	Patrick J Sullivan	CEO	Buy	45,000	$27.00	$1,215,000.00
5/13/2016	Bradley A Thomas	EVP	Buy	2,975	$26.63	$79,224.25
5/5/2016	Bradley A Thomas	EVP	Buy	1,656	$30.13	$49,895.28
3/10/2016	Daniel J Levangie	Insider	Sell	12,299	$30.89	$379,916.11
3/7/2016	Daniel J Levangie	Insider	Sell	7,663	$31.15	$238,702.45
3/2/2016	Jessica Hopfield	Director	Buy	3,230	$30.91	$99,839.30
6/5/2015	Patrick J Sullivan	CEO	Buy	10,000	$29.39	$293,900.00
5/28/2015	Patrick J Sullivan	CEO	Buy	20,000	$27.91	$558,200.00
5/15/2015	Timothy J Scannell	Director	Buy	3,500	$27.05	$94,675.00
5/5/2015	Bradley A Thomas	EVP	Buy	1,000	$27.26	$27,260.00
5/5/2015	Patrick Ryan	COO	Buy	3,669	$26.99	$99,026.31
4/2/2015	R Anthony Diehl	General Counsel	Sell	3,372	$30.96	$104,397.12
3/9/2015	Patrick J Sullivan	CEO	Buy	10,000	$31.93	$319,300.00
3/2/2015	Charles T Liamos	Director	Sell	4,000	$32.00	$128,000.00
2/12/2015	Charles T Liamos	Director	Sell	4,000	$32.00	$128,000.00
1/2/2015	Charles T Liamos	Director	Sell	4,000	$46.08	$184,320.00
11/3/2014	Charles T Liamos	Director	Sell	4,000	$42.95	$171,800.00
10/1/2014	Charles T Liamos	Director	Sell	4,000	$36.58	$146,320.00
10/1/2014	R Anthony Diehl	General Counsel	Sell	1,250	$36.59	$45,737.50
9/10/2014	Charles T Liamos	Director	Sell	4,000	$35.17	$140,680.00
9/2/2014	Duane Desisto	CEO	Sell	20,000	$36.30	$726,000.00
8/1/2014	Duane Desisto	CEO	Sell	20,000	$34.23	$684,600.00
7/1/2014	Duane Desisto	CEO	Sell	20,000	$40.52	$810,400.00
7/1/2014	R Anthony Diehl	General Counsel	Sell	1,250	$39.65	$49,562.50
6/11/2014	R Anthony Diehl	General Counsel	Sell	17,871	$37.09	$662,835.39
6/9/2014	Peter Devlin	Insider	Sell	12,314	$37.10	$456,849.40
4/8/2014	Peter Devlin	Insider	Sell	30,000	$41.25	$1,237,500.00
4/3/2014	R Anthony Diehl	General Counsel	Sell	4,617	$48.67	$224,709.39
3/6/2014	R Anthony Diehl	General Counsel	Sell	12,458	$49.28	$613,930.24
3/6/2014	Tracey Haas Wielinski	VP	Sell	8,275	$49.21	$407,212.75
2/3/2014	Charles Liamos	Director	Sell	11,037	$42.93	$473,818.41
2/3/2014	Duane Desisto	CEO	Sell	20,000	$42.95	$859,000.00
2/3/2014	Peter Devlin	Insider	Sell	30,000	$42.82	$1,284,600.00
1/3/2014	Charles Liamos	COO	Sell	86,000	$36.02	$3,097,720.00
1/2/2014	Duane Desisto	CEO	Sell	20,000	$36.07	$721,400.00
12/3/2013	Charles Liamos	COO	Sell	63,808	$36.26	$2,313,678.08
11/18/2013	Charles Liamos	COO	Sell	80,000	$35.60	$2,848,000.00
9/3/2013	Duane Desisto	CEO	Sell	20,000	$33.38	$667,600.00
8/29/2013	Sally Crawford	Director	Sell	9,000	$33.42	$300,780.00
8/15/2013	Regina Sommer	Director	Sell	5,000	$33.32	$166,600.00
8/1/2013	Duane Desisto	CEO	Sell	20,000	$31.85	$637,000.00
7/1/2013	Duane Desisto	CEO	Sell	20,000	$31.51	$630,200.00
7/1/2013	Peter Devlin	Insider	Sell	30,000	$31.48	$944,400.00
6/14/2013	Sally Crawford	Director	Sell	31,000	$30.47	$944,570.00
6/10/2013	R Anthony Diehl	General Counsel	Sell	38,455	$30.50	$1,172,877.50
6/3/2013	Duane Desisto	CEO	Sell	20,000	$29.76	$595,200.00
12/3/2012	Brian K Roberts	CFO	Sell	10,000	$21.92	$219,200.00
11/1/2012	Brian K Roberts	CFO	Sell	10,000	$21.49	$214,900.00
9/4/2012	Brian K Roberts	CFO	Sell	10,000	$20.78	$207,800.00
9/4/2012	Duane Desisto	CEO	Sell	20,000	$20.97	$419,400.00
9/4/2012	Ruthann Depietro	VP	Sell	1,000	$20.90	$20,900.00

(Data available from 1/1/2013 forward)

Latest Headlines for Insulet Corp. (NASDAQ:PODD)

Date	Headline
	Insulet Corporation to Announce Third Quarter 2016 Financial Results on November 3, 2016 (NASDAQ:PODD) www.publicnow.com - September 27 at 6:42 PM
	First Week of November 18th Options Trading For Insulet (PODD) (NASDAQ:PODD) www.nasdaq.com - September 24 at 6:09 PM
	Insulet Up 40.6% Since SmarTrend Uptrend Call (PODD) (NASDAQ:PODD) www.mysmartrend.com - September 22 at 11:39 AM
	Uptrend Call Working As Insulet Stock Rises 27.6% (PODD) (NASDAQ:PODD) www.mysmartrend.com - September 14 at 6:57 PM
	Insulet closes $345 private placement (NASDAQ:PODD) www.massdevice.com - September 14 at 6:57 PM
	Insulet Enrolls First Patients In Clinical Trial For Its Omnipod Artificial Pancreas System (NASDAQ:PODD) www.meddeviceonline.com - September 14 at 6:57 PM
	INSULET CORP Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Shee (NASDAQ:PODD) biz.yahoo.com - September 14 at 11:12 AM
	Insulet Corporation (PODD) - Financial and Strategic SWOT Analysis Review - New Report Available (NASDAQ:PODD) www.live-pr.com - September 13 at 11:42 AM
	Research Analysts Set Insulet Corporation (NASDAQ:PODD)’s Price Target At $43.477 (NASDAQ:PODD) www.realistinvestor.com - September 13 at 11:42 AM
	Insulet (PODD) Announces Enrollment of First Patient in Omnipod Horizon System Study (NASDAQ:PODD) www.streetinsider.com - September 13 at 11:42 AM
	Insulet Enrolls First Patients in Clinical Trial for its Omnipod ® Artificial Pancreas System (NASDAQ:PODD) www.businesswire.com - September 13 at 11:42 AM
	Insulet Enrolls First Patients in Clinical Trial for its Omnipod® Artificial Pancreas System (NASDAQ:PODD) www.publicnow.com - September 13 at 11:42 AM
	Insulet Announces Pricing of Convertible Senior Notes Due 2021 (NASDAQ:PODD) www.publicnow.com - September 8 at 10:41 AM
	3:17 am Insulet upsizes offering by $50 mln and prices $300 mln of 1.25% convertible senior notes due 2021 (NASDAQ:PODD) finance.yahoo.com - September 8 at 10:41 AM
	BRIEF-Insulet announces pricing of convertible senior notes due 2021 (NASDAQ:PODD) feeds.reuters.com - September 7 at 9:00 PM
	Insulet (PODD) to Offer $250M in Convertible Senior Notes (NASDAQ:PODD) www.streetinsider.com - September 7 at 6:59 PM
	INSULET CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:PODD) biz.yahoo.com - September 6 at 6:56 PM
	Insulet Announces Private Offering of Convertible Senior Notes (NASDAQ:PODD) www.publicnow.com - September 6 at 6:56 PM
	BRIEF-Insulet announces private offering of convertible senior notes (NASDAQ:PODD) feeds.reuters.com - September 6 at 5:39 PM
	Insulet to Establish Highly-Automated Manufacturing Operation in the United States (NASDAQ:PODD) www.publicnow.com - September 6 at 11:36 AM
	Insulet Announces Executive Appointments (NASDAQ:PODD) www.publicnow.com - September 6 at 11:36 AM
	Price Target For Insulet Corporation (NASDAQ:PODD) Set At $43.022 By Research Analysts (NASDAQ:PODD) www.realistinvestor.com - September 4 at 10:52 AM
	INSULET CORP Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:PODD) biz.yahoo.com - September 1 at 6:49 PM
	INSULET CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights of Secur (NASDAQ:PODD) biz.yahoo.com - September 1 at 9:58 AM
	Will Insulet (PODD) Crush Estimates at Its Next Earnings Report? (NASDAQ:PODD) finance.yahoo.com - September 1 at 9:58 AM
	ETF’s with exposure to Insulet Corp. : September 1, 2016 (NASDAQ:PODD) www.capitalcube.com - September 1 at 9:58 AM
	Uptrend Call Working As Insulet Stock Rises 35.8% (PODD) (NASDAQ:PODD) www.mysmartrend.com - August 30 at 6:47 PM
	Insulet (PODD): Field Checks Indicate Longer Term Upside - Piper Jaffray (NASDAQ:PODD) www.streetinsider.com - August 16 at 7:00 PM
	Moving Average Crossover Alert: Insulet (PODD) (NASDAQ:PODD) finance.yahoo.com - August 16 at 7:00 PM
	Can The Uptrend Continue for Insulet (PODD)? (NASDAQ:PODD) finance.yahoo.com - August 15 at 7:14 PM
	Insulet A Buy On Raised Growth Forecasts (NASDAQ:PODD) seekingalpha.com - August 11 at 7:23 PM
	INSULET CORP Financials (NASDAQ:PODD) finance.yahoo.com - August 11 at 7:23 PM
	ETF’s with exposure to Insulet Corp. : August 9, 2016 (NASDAQ:PODD) www.capitalcube.com - August 9 at 7:09 PM
	Insulet Corp. :PODD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016 (NASDAQ:PODD) www.capitalcube.com - August 8 at 7:07 PM
	Insulet Corp. (PODD) Surged To A New High After Guidance Increase (NASDAQ:PODD) www.rttnews.com - August 5 at 9:57 AM
	Insulet Reaches Analyst Target Price (NASDAQ:PODD) www.nasdaq.com - August 5 at 9:57 AM
	Insulet Corp. (PODD) Has Broken Out To A New High After Q2 Loss (NASDAQ:PODD) www.nasdaq.com - August 4 at 7:24 PM
	INSULET CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:PODD) biz.yahoo.com - August 4 at 7:24 PM
	Why Insulet Corporation Shares Are Soaring 19.5% Today (NASDAQ:PODD) www.fool.com - August 4 at 1:13 PM
	Insulet Delivers Healthy Q2 Revenue Growth; Stock Pumps Up Nearly 9% (NASDAQ:PODD) www.fool.com - August 4 at 11:37 AM
	Edited Transcript of PODD earnings conference call or presentation 3-Aug-16 8:30pm GMT (NASDAQ:PODD) finance.yahoo.com - August 4 at 10:03 AM
	Insulet Reports Second Quarter 2016 Financial Results (NASDAQ:PODD) www.stockhouse.com - August 3 at 7:15 PM
	Insulet reports 2Q loss (NASDAQ:PODD) sg.finance.yahoo.com - August 3 at 7:15 PM
	Q2 2016 Insulet Corp Earnings Release - After Market Close (NASDAQ:PODD) biz.yahoo.com - August 3 at 10:08 AM
	Insulet Corporation to Present at Upcoming Investor Conferences (NASDAQ:PODD) www.publicnow.com - August 1 at 6:39 PM
	Can Shares Of Insulet Corporation (NASDAQ:PODD) Hit $44? - Investor Newswire (NASDAQ:PODD) www.investornewswire.com - July 26 at 7:15 PM
	Price Target of $38.659 Set For Insulet Corporation (NASDAQ:PODD) - RealistInvestor.com (NASDAQ:PODD) www.realistinvestor.com - July 26 at 7:15 PM
	Insulet Corporation (NASDAQ:PODD) Short Interest Decreased By 1.6% - Consumer Eagle (NASDAQ:PODD) www.consumereagle.com - July 23 at 10:46 AM
	Earnings Focus and Crowd Sourced Sentiment Review for Insulet Corporation (NASDAQ:PODD) - TGP (NASDAQ:PODD) telanaganapress.com - July 21 at 7:11 PM
	Tracking Trading Performance for: Insulet Corporation (NASDAQ:PODD) - TGP (NASDAQ:PODD) telanaganapress.com - July 18 at 12:24 PM